JP2013501047A5 - - Google Patents

Download PDF

Info

Publication number
JP2013501047A5
JP2013501047A5 JP2012523650A JP2012523650A JP2013501047A5 JP 2013501047 A5 JP2013501047 A5 JP 2013501047A5 JP 2012523650 A JP2012523650 A JP 2012523650A JP 2012523650 A JP2012523650 A JP 2012523650A JP 2013501047 A5 JP2013501047 A5 JP 2013501047A5
Authority
JP
Japan
Prior art keywords
atoms
hal
nhco
conh
nhconh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012523650A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013501047A (ja
JP5718332B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/043467 external-priority patent/WO2011017142A1/en
Publication of JP2013501047A publication Critical patent/JP2013501047A/ja
Publication of JP2013501047A5 publication Critical patent/JP2013501047A5/ja
Application granted granted Critical
Publication of JP5718332B2 publication Critical patent/JP5718332B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012523650A 2009-08-06 2010-07-28 新規な二環式尿素化合物 Expired - Fee Related JP5718332B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23187309P 2009-08-06 2009-08-06
US61/231,873 2009-08-06
PCT/US2010/043467 WO2011017142A1 (en) 2009-08-06 2010-07-28 Novel bicyclic urea compounds

Publications (3)

Publication Number Publication Date
JP2013501047A JP2013501047A (ja) 2013-01-10
JP2013501047A5 true JP2013501047A5 (enExample) 2013-09-12
JP5718332B2 JP5718332B2 (ja) 2015-05-13

Family

ID=42985363

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012523650A Expired - Fee Related JP5718332B2 (ja) 2009-08-06 2010-07-28 新規な二環式尿素化合物

Country Status (14)

Country Link
US (1) US8569295B2 (enExample)
EP (1) EP2461869B1 (enExample)
JP (1) JP5718332B2 (enExample)
KR (1) KR20120055608A (enExample)
CN (1) CN102573994B (enExample)
AU (1) AU2010281368C1 (enExample)
CA (1) CA2770156C (enExample)
EA (1) EA201200218A1 (enExample)
ES (1) ES2433230T3 (enExample)
IL (1) IL217651A (enExample)
MX (1) MX2012001419A (enExample)
SG (1) SG178271A1 (enExample)
WO (1) WO2011017142A1 (enExample)
ZA (1) ZA201201635B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010045095A1 (en) 2008-10-14 2010-04-22 Ning Xi Compounds and methods of use
WO2010111063A1 (en) 2009-03-21 2010-09-30 Ning Xi Amino ester derivatives, salts thereof and methods of use
US9290485B2 (en) 2010-08-04 2016-03-22 Novartis Ag N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
EP2680886B1 (en) 2011-02-28 2016-08-10 Calitor Sciences, LLC Substituted quinoline compounds
CA2844588A1 (en) * 2011-08-10 2013-02-14 Merck Patent Gmbh Pyrido-pyrimidine derivatives
GB201201566D0 (en) * 2012-01-30 2012-03-14 Vernalis R&D Ltd New chemical compounds
JP6342392B2 (ja) 2012-07-28 2018-06-13 カリター・サイエンシーズ・エルエルシー 置換型ピラゾロン化合物及び使用方法
US8975282B2 (en) 2012-07-28 2015-03-10 Sunshine Lake Pharma Co., Ltd. Substituted pyrazolone compounds and methods of use
CA2883172A1 (en) 2012-08-29 2014-03-06 Merck Patent Gmbh Ddr2 inhibitors for the treatment of osteoarthritis
MD4635C1 (ro) 2013-10-14 2020-01-31 Eisai R&D Management Co., Ltd. Compuşi de chinolină substituiţi selectiv
WO2015057655A1 (en) 2013-10-14 2015-04-23 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
CN106279147A (zh) * 2015-05-21 2017-01-04 中国科学院上海药物研究所 一种吡啶并氮杂环化合物及其制备方法和用途
WO2017174879A1 (en) * 2016-04-06 2017-10-12 University Of Oulu Compounds for use in the treatment of cancer
EA201992584A1 (ru) * 2017-05-26 2020-06-18 Икнос Сайенсиз Са Новые ингибиторы map4k1
GB2575490A (en) * 2018-07-12 2020-01-15 Recordati Ind Chimica E Farmaceutica Spa P2X3 receptor antagonists
WO2020038460A1 (zh) * 2018-08-24 2020-02-27 南京药捷安康生物科技有限公司 一种新型的喹啉衍生物抑制剂
US12378245B2 (en) * 2019-02-11 2025-08-05 Phoenix Molecular Designs Crystalline forms of an RSK inhibitor
CN112625026B (zh) * 2019-09-24 2022-09-09 药捷安康(南京)科技股份有限公司 Tam家族激酶抑制剂的喹啉衍生物
PE20230823A1 (es) 2020-03-30 2023-05-19 Hutchison Medipharma Ltd Compuestos de amida y usos de los mismos
CN112225748B (zh) * 2020-10-20 2021-11-30 四川大学华西医院 一种具有flt3激酶抑制活性的小分子化合物及其应用
WO2022175514A1 (en) 2021-02-22 2022-08-25 Bayer Aktiengesellschaft N-(pyridin-2-yl)-acetamides as p2x3 inhibitors
KR102726416B1 (ko) * 2021-12-15 2024-11-05 한국과학기술연구원 엑토뉴클레오티드 피로포스파타아제-포스포디에스터라아제의 저해 활성을 갖는 신규한 피리도피리미딘 유도체 및 이들의 용도
US11753395B2 (en) 2021-12-16 2023-09-12 Kinnate Biopharma Inc. Inhibitors of MET kinase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005533039A (ja) * 2002-05-29 2005-11-04 アムゲン インコーポレイテッド 細胞増殖関連疾患治療用2−オキソ−1,3,4−トリヒドロキナゾリニル誘導体
DE102004004731A1 (de) * 2004-01-30 2005-08-18 Merck Patent Gmbh Harnstoffderivate
CA2600886A1 (en) * 2005-03-08 2006-09-14 Biota Scientific Management Pty Ltd. Bicyclic nucleosides and nucleotides as therapeutic agents
EP1881983B1 (en) * 2005-05-20 2012-01-11 Vertex Pharmaceuticals, Inc. Pyrrolopyridines useful as inhibitors of protein kinase

Similar Documents

Publication Publication Date Title
JP2013501047A5 (enExample)
JP2013521295A5 (enExample)
JP2013518107A5 (enExample)
JP2010265321A5 (enExample)
JP2012092103A5 (enExample)
JP2014511891A5 (enExample)
JP2016503797A5 (enExample)
JP2012506389A5 (enExample)
JP2013542218A5 (enExample)
JP2012532899A5 (enExample)
JP2013527242A5 (enExample)
JP2016530259A5 (enExample)
JP2013518832A5 (enExample)
JP2008510828A5 (enExample)
JP2013544860A5 (enExample)
AR086095A1 (es) Derivados de nucleosidos 2’-sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
RU2012110246A (ru) Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора
JP2015501833A5 (enExample)
JP2014511892A5 (enExample)
JP2013534248A5 (enExample)
JP2012072150A5 (enExample)
JP2018528942A5 (enExample)
RU2014141579A (ru) Гетероциклические соединения в качестве ингибиторов бета-лактамаз
JP2013508279A5 (enExample)
IN2014CN04127A (enExample)